Anteris Technologies Global Corp.

NasdaqGM:AVR Stock Report

Market Cap: US$854.5m

Anteris Technologies Global Management

Management criteria checks 2/4

Anteris Technologies Global's CEO is Wayne Paterson, appointed in May 2016, has a tenure of 10.08 years. total yearly compensation is $6.13M, comprised of 12% salary and 88% bonuses, including company stock and options. directly owns 0.21% of the company’s shares, worth $1.78M. The average tenure of the management team and the board of directors is 6.2 years and 4.1 years respectively.

Key information

Wayne Paterson

Chief executive officer

US$6.1m

Total compensation

CEO salary percentage11.98%
CEO tenure10.1yrs
CEO ownership0.2%
Management average tenure6.2yrs
Board average tenure4.1yrs

Recent management updates

Recent updates

Seeking Alpha Apr 23

Anteris Technologies Looks Bullish If DurAVR's PARADIGM Delivers

Summary Anteris Technologies is developing DurAVR, a differentiated biomimetic TAVR device with encouraging early clinical data in over 130 patients. AVR’s PARADIGM pivotal trial is the central catalyst. This will compare DurAVR against commercial valves across 85 sites in the US, Europe, and Canada. I believe that Medtronic’s 16.2% stake also offers strategic validation of AVR’s underlying valve technology. And, after AVR’s recent raises, its balance sheet seems well capitalized despite ongoing cash burn. AVR remains speculative until they receive full regulatory approvals. But I feel the upside potential justifies those risks in the long run. Read the full article on Seeking Alpha

CEO Compensation Analysis

How has Wayne Paterson's remuneration changed compared to Anteris Technologies Global's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2026n/an/a

-US$95m

Dec 31 2025US$6mUS$735k

-US$94m

Sep 30 2025n/an/a

-US$84m

Jun 30 2025n/an/a

-US$84m

Mar 31 2025n/an/a

-US$82m

Dec 31 2024US$3mUS$696k

-US$76m

Sep 30 2024n/an/a

-US$71m

Jun 30 2024n/an/a

-US$60m

Mar 31 2024n/an/a

-US$52m

Dec 31 2023US$7mUS$676k

-US$46m

Sep 30 2023n/an/a

-US$39m

Jun 30 2023n/an/a

-US$36m

Mar 31 2023n/an/a

-US$33m

Dec 31 2022US$2mUS$613k

-US$30m

Sep 30 2022n/an/a

-US$25m

Jun 30 2022n/an/a

-US$24m

Mar 31 2022n/an/a

-US$22m

Dec 31 2021US$1mUS$604k

-US$17m

Sep 30 2021n/an/a

-US$15m

Jun 30 2021n/an/a

-US$15m

Mar 31 2021n/an/a

-US$13m

Dec 31 2020US$1mUS$639k

-US$12m

Sep 30 2020n/an/a

-US$6m

Jun 30 2020n/an/a

-US$162k

Mar 31 2020n/an/a

-US$2m

Dec 31 2019US$1mUS$630k

-US$4m

Compensation vs Market: Wayne's total compensation ($USD6.13M) is above average for companies of similar size in the US market ($USD3.69M).

Compensation vs Earnings: Wayne's compensation has increased whilst the company is unprofitable.


CEO

Wayne Paterson (59 yo)

10.1yrs
Tenure
US$6,131,101
Compensation

Mr. Wayne Geoffrey Paterson is Chief Executive Officer, Managing Director and Executive Director of Anteris Technologies Ltd from March 2017. He joined the Anteris Technologies Ltd on October 10, 2014. He...


Leadership Team

NamePositionTenureCompensationOwnership
Wayne Paterson
Vice Chairman & CEO10.1yrsUS$6.13m0.21%
$ 1.8m
David Denis
President & Director1.3yrsUS$981.91k0.10%
$ 887.4k
Matthew McDonnell
Chief Financial Officer7.6yrsUS$457.35k0.029%
$ 243.9k
Chris Meduri
Chief Medical Officer & Member of Medical Advisory Board4.8yrsno datano data
6.2yrs
Average Tenure
57yo
Average Age

Experienced Management: AVR's management team is seasoned and experienced (6.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Wayne Paterson
Vice Chairman & CEO11.7yrsUS$6.13m0.21%
$ 1.8m
David Denis
President & Director1.3yrsUS$981.91k0.10%
$ 887.4k
Chris Meduri
Chief Medical Officer & Member of Medical Advisory Boardno datano datano data
Martin B. Leon
Member of Global Medical Advisory Board3.9yrsno datano data
John Seaberg
Independent Chairman of the Board11.7yrsUS$777.31k0.049%
$ 416.8k
Gregory Moss
Independent Non-Executive Director1yrUS$329.35k0.018%
$ 154.3k
Stephen Denaro
Non-Executive Directorless than a yearUS$436.62k0.024%
$ 208.3k
Bernard Prendergast
TAVR Medical Advisory Board5.8yrsno datano data
Karl Poon
Member of Medical Advisory Board4.3yrsno datano data
Paul Sorajja
Member of Medical Advisory Boardno datano datano data
Vinayak Bapat
Member of Global TAVR Medical Advisory Boardno datano datano data
Dion Stub
Member of Medical Advisory Board4.1yrsno datano data
4.1yrs
Average Tenure
59yo
Average Age

Experienced Board: AVR's board of directors are considered experienced (4.1 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/17 23:52
End of Day Share Price 2026/06/17 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Anteris Technologies Global Corp. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew MiksicBarclays
John HesterBell Potter
Ross OsbornCantor Fitzgerald & Co.